Chorionic villus sampling (CVS) is a prenatal procedure for the removal by needle of chorionic villi and culture and examination of the fetal cells obtained. The cells are used in tests for genetic and chromosomal abnormalities of a fetus as early as 10 to 12 weeks of gestation.
Women who are at risk of carrying a fetus with a genetic or chromosomal defect may be counseled to have a prenatal screening test such as CVS or amniocentesis. CVS, which is performed at 10 to 12 weeks after a woman's last menstrual period, may be offered as an alternative to amniocentesis, the more commonly used test for prenatal diagnosis of genetic disorders, which is performed usually at 15 to 18 weeks. Earlier diagnosis of congenital defects is especially beneficial in cases where the parents' desire to know the results as early in preg- nancy as possible, for instance, when therapeutic abortion is being considered, as the risks associated with abortion increase with gestational age.
Prenatal screening can diagnose some genetic and virtually all chromosomal disorders and is advised for women who have one or more of the following risk factors:
|
|
Author Info: Patricia L. Bounds Ph.D., The Gale Group Inc., Gale, Detroit, Gale Encyclopedia of Nursing and Allied Health, 2002 |